Cargando…

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with a significant mortality, health and economic burden. Their diagnosis, assessment and management remain suboptimal and unchanged for decades. Recent clinical and translational studies revealed that the significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathioudakis, Alexander G, Janssens, Wim, Sivapalan, Pradeesh, Singanayagam, Aran, Dransfield, Mark T, Jensen, Jens-Ulrik Stæhr, Vestbo, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279206/ https://www.ncbi.nlm.nih.gov/pubmed/32217784 http://dx.doi.org/10.1136/thoraxjnl-2019-214484

Ejemplares similares

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
por: Bergsøe, Christina Marisa, et al.
Publicado: (2021)

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study
por: Mathioudakis, Alexander G., et al.
Publicado: (2021)

The environmental impact of inhaled therapy: making informed treatment choices
por: Woodcock, Ashley, et al.
Publicado: (2022)

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2023)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
por: Kamstrup, Peter, et al.
Publicado: (2023)

Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients
por: Rønn, Christian, et al.
Publicado: (2023)

Automated oxygen control with O2matic(®) during admission with exacerbation of COPD
por: Hansen, Ejvind Frausing, et al.
Publicado: (2018)

Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
por: Bagge, Kristian, et al.
Publicado: (2021)

Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure
por: Holm, Freja Stæhr, et al.
Publicado: (2019)

Recent developments in the management of severe asthma
por: Meteran, Howraman, et al.
Publicado: (2022)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study
por: Kamstrup, Peter, et al.
Publicado: (2023)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
por: Bonnesen, Barbara, et al.
Publicado: (2021)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Sedating antihistamine treatment with promethazine in patients with severe COPD with and without asthma: death and severe exacerbations in a nationwide register study
por: Bonnesen, Barbara, et al.
Publicado: (2023)

Treatable traits in acute exacerbations of chronic airway diseases
por: McDonald, Vanessa M, et al.
Publicado: (2019)

The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study
por: Toennesen, Louise Lindhardt, et al.
Publicado: (2022)

Does inhaled corticosteroid use affect the risk of  COVID-19-related death?
por: Jordan, Alexander, et al.
Publicado: (2021)

Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Does aspirin-induced oxidative stress cause asthma exacerbation?
por: Kacprzak, Dorota, et al.
Publicado: (2015)

Building toolkits for COPD exacerbations: lessons from the past and present
por: Sapey, Elizabeth, et al.
Publicado: (2019)

The search for allelic variants that cause monogenic disorders or predispose to common, complex polygenic phenotypes
por: Antonarakis, Stylianos E.
Publicado: (2001)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Affective preclinical modeling of psychiatric disorders: taking imbalanced primal emotional feelings of animals seriously in our search for novel antidepressants
por: Panksepp, Jaak
Publicado: (2015)

Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance
por: Murray, Daniel D., et al.
Publicado: (2019)

Eosinophilic Chronic Obstructive Pulmonary Disease
por: Weissler, Jonathan C., et al.
Publicado: (2021)

Management of hypertension in obstructive sleep apnea
por: Ou, Yi-Hui, et al.
Publicado: (2023)

Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023)

Obstructive sleep apnea and hormones – a novel insight
por: Ruchała, Marek, et al.
Publicado: (2016)

Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
por: Kamstrup, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjd62n11d2ifs84h23kvfsuqqq